Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Direct-acting antivirals lower the risk of cardiovascular disease to a greater extent than interferon-based regimens.
Hepatitis C knocked pro wrestler Devon “Hannibal” Nicholson out of the ring, but a cure landed him back in the fight.
This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.
Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen.
In a recent trial, 12 weeks of the drug combination worked well regardless of whether individuals had drug-resistant virus.
This hep story teller and her husband describe their hepatitis C treatments using peginterferon and ribavirin as a wild ride.
Human rights activist Philip Baldwin writes about his experiences living with hepatitis C and HIV, and his treatment for hep C.
The FDA has expanded approval of the direct-acting antiviral treatments Sovaldi and Harvoni for adolescents ages 12 and older.
A look at hepatitis C treatment side effects using the newest medicines.
Will your hepatitis C treatment work if your doctor reduces your ribavirin dose?
An analysis of forty-two clinical trials of all the approved direct acting antiviral HCV regimens.
Hepatitis C advocate Peter McLoyd transformed his bad times into good ones.
A look at the latest hepatitis C treatment for children and teens.
The antiviral drug, which for some people can be a beneficial adjunct to the new crop of hep C medications, has gotten a bad rap.
As a hepatitis C navigator, Glenna McCarthy highlights the importance of self-care.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.